201 related articles for article (PubMed ID: 8586704)
1. Identification and antimicrobial resistance patterns of clinical isolates of Clostridium clostridioforme, Clostridium innocuum, and Clostridium ramosum compared with those of clinical isolates of Clostridium perfringens.
Alexander CJ; Citron DM; Brazier JS; Goldstein EJ
J Clin Microbiol; 1995 Dec; 33(12):3209-15. PubMed ID: 8586704
[TBL] [Abstract][Full Text] [Related]
2. Clostridium innocuum is a significant vancomycin-resistant pathogen for extraintestinal clostridial infection.
Chia JH; Feng Y; Su LH; Wu TL; Chen CL; Liang YH; Chiu CH
Clin Microbiol Infect; 2017 Aug; 23(8):560-566. PubMed ID: 28254687
[TBL] [Abstract][Full Text] [Related]
3. In vitro activities of the new semisynthetic glycopeptide telavancin (TD-6424), vancomycin, daptomycin, linezolid, and four comparator agents against anaerobic gram-positive species and Corynebacterium spp.
Goldstein EJ; Citron DM; Merriam CV; Warren YA; Tyrrell KL; Fernandez HT
Antimicrob Agents Chemother; 2004 Jun; 48(6):2149-52. PubMed ID: 15155214
[TBL] [Abstract][Full Text] [Related]
4. The antibiotic susceptibility pattern of gas gangrene-forming
Sárvári KP; Schoblocher D
Infect Dis (Lond); 2020 Mar; 52(3):196-201. PubMed ID: 31778089
[No Abstract] [Full Text] [Related]
5. In vitro activity of gemifloxacin (SB 265805) against anaerobes.
Goldstein EJ; Citron DM; Warren Y; Tyrrell K; Merriam CV
Antimicrob Agents Chemother; 1999 Sep; 43(9):2231-5. PubMed ID: 10471570
[TBL] [Abstract][Full Text] [Related]
6. How far should a clinical laboratory go in identifying anaerobic isolates, and who should pay?
Citron DM; Appelbaum PC
Clin Infect Dis; 1993 Jun; 16 Suppl 4():S435-8. PubMed ID: 8324163
[TBL] [Abstract][Full Text] [Related]
7. In vitro activities of daptomycin, vancomycin, quinupristin- dalfopristin, linezolid, and five other antimicrobials against 307 gram-positive anaerobic and 31 Corynebacterium clinical isolates.
Goldstein EJ; Citron DM; Merriam CV; Warren YA; Tyrrell KL; Fernandez HT
Antimicrob Agents Chemother; 2003 Jan; 47(1):337-41. PubMed ID: 12499210
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility of Clostridium ramosum to antimicrobial agents.
Tally FP; Armfield AY; Dowell VR; Kwok YY; Sutter VL; Finegold SM
Antimicrob Agents Chemother; 1974 Jun; 5(6):589-93. PubMed ID: 15825410
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility of Clostridium perfringens type A to 23 antimicrobial drugs.
Traub WH; Karthein J; Spohr M
Chemotherapy; 1986; 32(5):439-45. PubMed ID: 2875853
[TBL] [Abstract][Full Text] [Related]
10. Clostridium clostridioforme: a mixture of three clinically important species.
Finegold SM; Song Y; Liu C; Hecht DW; Summanen P; Könönen E; Allen SD
Eur J Clin Microbiol Infect Dis; 2005 May; 24(5):319-24. PubMed ID: 15891914
[TBL] [Abstract][Full Text] [Related]
11. Emerging resistance of anaerobic bacteria to antimicrobial agents in South Korea.
Lee K; Chong Y; Jeong SH; Xu XS; Kwon OH
Clin Infect Dis; 1996 Dec; 23 Suppl 1():S73-7. PubMed ID: 8953110
[TBL] [Abstract][Full Text] [Related]
12. [In vitro effect of piperacillin, amoxicillin, cefoxitin and metronidazole against obligate anaerobic bacteria].
Derriennic M; Reynaud A; Launay C; Courtieu AL
Presse Med; 1986 Dec; 15(46):2279-81. PubMed ID: 2949268
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial susceptibilities of canine Clostridium difficile and Clostridium perfringens isolates to commonly utilized antimicrobial drugs.
Marks SL; Kather EJ
Vet Microbiol; 2003 Jun; 94(1):39-45. PubMed ID: 12742714
[TBL] [Abstract][Full Text] [Related]
14. In vitro activities of dalbavancin and nine comparator agents against anaerobic gram-positive species and corynebacteria.
Goldstein EJ; Citron DM; Merriam CV; Warren Y; Tyrrell K; Fernandez HT
Antimicrob Agents Chemother; 2003 Jun; 47(6):1968-71. PubMed ID: 12760876
[TBL] [Abstract][Full Text] [Related]
15. [Studies on Clostridium absonum isolates from clinical specimens].
Masaki T; Nagata K; Nakamura S
Kansenshogaku Zasshi; 1992 Mar; 66(3):302-5. PubMed ID: 1624818
[TBL] [Abstract][Full Text] [Related]
16. Low-level vancomycin resistance in Clostridium innocuum.
Mory F; Lozniewski A; David V; Carlier JP; Dubreuil L; Leclercq R
J Clin Microbiol; 1998 Jun; 36(6):1767-8. PubMed ID: 9620417
[TBL] [Abstract][Full Text] [Related]
17. Clostridium innocuum is a vancomycin-resistant pathogen that may cause antibiotic-associated diarrhoea.
Chia JH; Wu TS; Wu TL; Chen CL; Chuang CH; Su LH; Chang HJ; Lu CC; Kuo AJ; Lai HC; Chiu CH
Clin Microbiol Infect; 2018 Nov; 24(11):1195-1199. PubMed ID: 29458157
[TBL] [Abstract][Full Text] [Related]
18. Clostridium perfringens and Clostridium difficile in cooked beef sold in Côte d'Ivoire and their antimicrobial susceptibility.
Kouassi KA; Dadie AT; N'Guessan KF; Dje KM; Loukou YG
Anaerobe; 2014 Aug; 28():90-4. PubMed ID: 24944124
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial resistance among Clostridium perfringens isolated from various sources in Thailand.
Tansuphasiri U; Matra W; Sangsuk L
Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):954-61. PubMed ID: 16295551
[TBL] [Abstract][Full Text] [Related]
20. Comparative genomics of Clostridium bolteae and Clostridium clostridioforme reveals species-specific genomic properties and numerous putative antibiotic resistance determinants.
Dehoux P; Marvaud JC; Abouelleil A; Earl AM; Lambert T; Dauga C
BMC Genomics; 2016 Oct; 17(1):819. PubMed ID: 27769168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
